Dergiler / Journal of Medicine and Palliative Care / 2026 / Volume: 7 Issue: 1

Beyond atopy: etiological evaluation of markedly elevated serum total IgE (>1000 IU/ml)

Şeyma Özden(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL SÜREYYAPAŞA GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0002-6646-9894
Arzu Karasu Çelik(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL SÜREYYAPAŞA HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY)0009-0008-1852-9929
Fatma Merve Tepetam(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL SÜREYYAPAŞA HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY)0000-0002-9794-5662
Özge Atik(University of Health Sciences, Van Training and Research Hospital, Department of Immunology and Allergy, Van, Türkiye)0000-0003-2219-0039
Bengü Kaan(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL SÜREYYAPAŞA HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY)0000-0002-5922-0847
Sayfa
—
Yayın Tarihi
2026-02-20
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A systematic and multidisciplinary diagnostic approach is essential to accurately identify the underlying cause of IgE elevation and to guide appropriate clinical management.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: Marked elevation of serum total immunoglobulin E (IgE) levels (>1000 IU/ml) is most commonly associated with atopic diseases; however, its underlying etiology is highly heterogeneous.
📊
Temel Bulgular & Veri:Methods: Medical records of 1103 patients with serum total IgE levels >1000 IU/ml who presented to the allergy and immunology outpatient clinic between January 1 and September 1, 2023, were retrospectively reviewed.
💡
Sonuç & Katkı:A systematic and multidisciplinary diagnostic approach is essential to accurately identify the underlying cause of IgE elevation and to guide appropriate clinical management.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2023 Verileri
⚙️Değişkenler:Total IgE · atopic diseases · etiology

Abstract

Aims: Marked elevation of serum total immunoglobulin E (IgE) levels (>1000 IU/ml) is most commonly associated with atopic diseases; however, its underlying etiology is highly heterogeneous. This study aimed to systematically evaluate the etiological factors associated with markedly elevated serum total IgE levels in patients attending an allergy and immunology outpatient clinic. Methods: Medical records of 1103 patients with serum total IgE levels >1000 IU/ml who presented to the allergy and immunology outpatient clinic between January 1 and September 1, 2023, were retrospectively reviewed. Patients with only a single outpatient visit and those who did not undergo adequate diagnostic evaluation to determine the cause of IgE elevation were excluded. A total of 643 patients who completed comprehensive clinical, laboratory, and diagnostic assessments were included in the final analysis. Etiological causes of IgE elevation were classified based on clinical and laboratory findings. Results: The mean age of the 643 patients was 47.55±17.00 years, and 52.9% were female. The median serum total IgE level was 1520 (1001–62,753) IU/ml. Atopic diseases were identified as the most common etiological factor (n:530, 82.4%). Other causes included infectious diseases (5.3%), inflammatory diseases (1.2%), neoplasms (0.5%), primary immunodeficiency disorders (0.2%), drug-related causes (0.2%), and other conditions (0.2%). Despite comprehensive evaluation, no underlying cause could be identified in 65 patients (10.1%), who were classified as having idiopathic total IgE elevation. Conclusion: Although markedly elevated serum total IgE levels are predominantly associated with atopic diseases, a substantial proportion of patients have alternative or unidentified etiologies. A systematic and multidisciplinary diagnostic approach is essential to accurately identify the underlying cause of IgE elevation and to guide appropriate clinical management.

🔖

Bu Makaleye Atıf Yap

Özden, Ş., Çelik, A. K., Tepetam, F. M., Atik, Ö., Kaan, B. (2026). Beyond atopy: etiological evaluation of markedly elevated serum total IgE (>1000 IU/ml). Journal of Medicine and Palliative Care, Volume: 7 Issue: 1. https://doi.org/10.47582/jompac.1868300

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (23)

  1. Ogulur I, Mitamura Y, Yazici D, et al. Type 2 immunity in allergic diseases. Cell Mol Immunol. 2025;22(3):211-242. doi:10.1038/s41423-025-01261-2
  2. Bachert C, Hicks A, Gane S, et al. The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps. Front Immunol. 202416;15:1356298. doi:10.3389/fimmu.2024.1356298
  3. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012; 18(5):693-704. doi:10.1038/nm.2755
  4. Bochner BS, Stokes J. The biology of IgE. Up to Date. 2025.
  5. Al-Mughales JA. Diagnostic utility of total IgE in foods, inhalant, and multiple allergies in Saudi Arabia. J Immunol Res. 2016;2016:1058632. doi:10.1155/2016/1058632
  6. Maizels RM, McSorley HJ. Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol. 2016;138(3):666-675. doi:10. 1016/j.jaci.2016.07.007
  7. Agarwal R, Sehgal IS, Muthu V, et al. Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses. Eur Respir J. 2024;63(4):2400061. doi:10.1183/13993003.00061-2024
  8. Sutanto H, Adytia GJ, Fetarayani D. Hyper IgE syndrome: bridging the gap between immunodeficiency, atopy, and allergic diseases. Curr Allergy Asthma Rep. 2025;25(1):17. doi:10.1007/s11882-025-01196-8
  9. Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008;8(3):205-217. doi:10.1038/nri2273
  10. Bousquet J, Humbert M, Gibson PG, et al. Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies. J Allergy Clin Immunol Pract. 2021;9(7):2702-2714. doi:10.1016/j.jaip.2021.01.011
  11. Nemet S, Elbirt D, Cohen R, et al. Clinical significance of very high IgE levels (≥1000 IU/ml): population-based study of 118,211 adults. J Allergy Clin Immunol Glob. 2025;4(2):100403. doi:10.1016/j.jacig.2025.100403
  12. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S73-S80. doi: 10.1016/j.jaci.2009.11.017
  13. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113(5):832-836. doi:10.1016/j.jaci.2003.12.591
  14. Siroux V, Ballardini N, Soler M, et al. The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults. Allergy. 2018;73(7):1447-1458. doi:10.1111/all.13410
  15. Cooper PJ. Interactions between helminth parasites and allergy. Curr Opin Allergy Clin Immunol. 2009;9(1):29-37. doi:10.1097/ACI.0b013e 32831f44a6
  16. Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am. 2007;27(3):529-549. doi: 10.1016/j.iac.2007.07.008
  17. Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017; 376(20):1921-1932. doi:10.1056/NEJMoa1702079
  18. Vaglio A, Moosig F, Zwerina J. Churg–Strauss syndrome: update on pathophysiology and treatment. Curr Opin Rheumatol. 2012;24(1):24-30. doi:10.1097/BOR.0b013e32834d85ce
  19. Chen H, Thompson LD, Aguilera NS, Abbondanzo SL. Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2004;28(4):505-513. doi:10.1097/00000478-200404000-00010
  20. Kelesidis T, Yang O. Good’s syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol. 2010;135(3): 347-363. doi:10.1016/j.clim.2010.01.006
  21. Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608-1619. doi:10.1056/NEJMoa073687
  22. Pichler WJ. Drug hypersensitivity reactions: classification and relationship to T-cell activation. Curr Opin Allergy Clin Immunol. 2004; 4(4):313-319. doi:10.1097/00130832-200408000-00010
  23. Freeman AF, Holland SM. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res. 2009;65(5 Pt 2): 32R-37R. doi:10.1203/PDR.0b013e31819dc8c5